8-K: RYAM Reports Deep Q2 Loss, Cuts 2025 Outlook

Rayonier Advanced Materials Inc. reported a significant net loss of $363 million in Q2 2025, driven by a large non-cash tax write-off and operational headwinds, leading to a downward revision of its full-year Adjusted EBITDA guidance.

Summary

• Reported a net loss of $363 million, or $(5.44) per diluted share, for Q2 2025, compared to net income of $11 million, or $0.17 per diluted share, in the prior year quarter.
• Loss from continuing operations was $366 million, including a $337 million non-cash Canadian deferred tax asset write-off.
• Adjusted EBITDA from continuing operations for Q2 2025 was $28 million, down from $68 million in Q2 2024.
• Net sales for Q2 2025 were $340 million, a decrease from $419 million in Q2 2024.
• Revised full-year 2025 Adjusted EBITDA guidance to $150 million to $160 million, down from an approximated $200 million.
• Revised full-year 2025 Adjusted Free Cash Flow guidance to $(10) million to $(25) million.
• Year-to-date cash provided by operating activities was $10 million, and Adjusted Free Cash Flow was $(52) million.
• Total Debt stood at $746 million and Net Secured Debt at $688 million as of June 28, 2025.
• The company reorganized its High Purity Cellulose segment into Cellulose Specialties, Biomaterials, and Cellulose Commodities in January 2025.

Sentiment

Score: 3

Explanation: The sentiment is largely negative due to a substantial net loss, a significant non-cash write-off, and a downward revision of full-year guidance. While management expresses long-term optimism and highlights some operational improvements, the immediate financial performance and strategic delays overshadow these positives, indicating a challenging near-term outlook.

Positives

• Long-term strategic direction and value creation remain firmly intact, with a plan to nearly double EBITDA over the next two years relative to the revised 2025 outlook, targeting over $300 million in run-rate EBITDA by the end of 2027.
• Extraordinary headwinds encountered in 2025 are largely considered to have peaked in Q2, with tangible signs of stabilization and recovery entering the second half of the year.
• Order trends in Cellulose Specialties have improved month over month since May, and operational performance across cellulose facilities has remained broadly stable.
• Cellulose Specialties average sales prices are expected to increase by a mid single-digit percentage in 2025.
• Ethers volumes are anticipated to improve, and demand for other cellulose specialties grades remains strong, supported by tight global supply conditions.
• All cellulose plants are currently running at expected operating rates.
• The company secured green capital of €67 million in Q4 2024 to advance its biomaterials strategy.
• The bioethanol facility in France has been operational since Q1 2024, and the lignosulfonate powder plant in France re-started in Q1 2025.
• Received GRAS (generally recognized as safe) status for its prebiotics product from the U.S. Food and Drug Administration in July 2025.
• Signed Memoranda of Understanding with Verso Energy and GranBio to explore Sustainable Aviation Fuel (SAF) opportunities.
• Strong working capital management contributed to positive operating cash flows despite the significant decline in operating results.

Negatives

• Reported a net loss of $363 million in Q2 2025, a significant decline from net income of $11 million in Q2 2024.
• Loss from continuing operations was $366 million, primarily due to a $337 million non-cash Canadian deferred tax asset write-off.
• Adjusted EBITDA from continuing operations decreased to $28 million in Q2 2025 from $68 million in Q2 2024.
• Net sales decreased by 19% to $340 million in Q2 2025 compared to $419 million in Q2 2024.
• Full-year 2025 Adjusted EBITDA guidance was revised down to $150 million to $160 million from an implied $200 million.
• Full-year 2025 Adjusted Free Cash Flow guidance is negative, ranging from $(10) million to $(25) million.
• Sales volumes decreased across most segments: Cellulose Specialties (15%), Cellulose Commodities (33%), Paperboard (23%), and High-Yield Pulp (7%) compared to the prior year quarter.
• Operating income for Cellulose Specialties decreased by 42% due to lower sales volumes, higher input costs, and operational challenges including a labor strike.
• Paperboard and High-Yield Pulp businesses experienced declines in sales prices and volumes due to economic uncertainty, increased competition, and oversupply in the Chinese market.
• The company is idling Paperboard production for two weeks and High-Yield Pulp production for three weeks during Q3 to manage inventory and preserve cash flow.
• The process to explore the sale of its Paperboard and High-Yield Pulp businesses is effectively on hold due to current market conditions and trade-related uncertainty.
• The City of Fernandina Beach recently denied the site plan application for a bioethanol facility project, requiring the company to pursue legal remedies.
• Chinese retaliatory tariffs continue to disrupt global fluff market dynamics, impacting Cellulose Commodities.
• Corporate costs for full year 2025 are expected to be higher due to a $12 million non-cash environmental reserve charge and potential foreign exchange headwinds.

Risks

• The company's business, financial condition, and results of operations could be adversely affected by disruptions in the global economy caused by geopolitical conflicts and related impacts.
• The businesses the company operates are highly competitive and many are cyclical, which may result in fluctuations in pricing and volume.
• Changes in the availability and price of raw materials and energy, and continued inflationary pressure, could have a material adverse effect.
• The company is subject to material risks associated with doing business outside of the United States, including foreign currency exchange fluctuations.
• Restrictions on trade through tariffs, countervailing and anti-dumping duties, quotas, and other trade barriers could materially adversely affect market access.
• The company is subject to risks associated with epidemics and pandemics.
• Reliance on a significant portion of revenue from its ten largest customers (in 2024) poses a risk if revenue from these customers is lost.
• A material disruption at any manufacturing plant could prevent meeting customer demand, reduce sales and profitability, and increase costs.
• Unfavorable changes in the availability of, and prices for, wood fiber may have a material adverse impact.
• Substantial capital is required to maintain production facilities, and the cost to repair or replace equipment, as well as associated downtime, could materially adversely affect the business.
• The company faces risks to its assets, including the potential for substantial impairment of long-lived assets.
• The company may be required to recognize a significant non-cash charge to earnings if its recorded deferred tax assets are deemed unrealizable.
• Dependence on third parties for transportation services and unfavorable changes in cost and availability could materially adversely affect the business.
• Failure to maintain satisfactory labor relations could have a material adverse effect.
• Dependence on attracting and retaining key personnel, the loss of whom could materially adversely affect the business.
• Failure to meet customer needs through new product development or inability to protect intellectual property could have a material adverse impact.
• Loss of company intellectual property and sensitive data or disruption of manufacturing operations due to a cybersecurity incident could materially adversely impact the business.
• Challenges and uncertainties in executing the Biomaterials strategy may adversely impact its business and financial results.
• The business is subject to extensive environmental laws, regulations, and permits that may materially restrict or adversely affect operations and financial results.
• The potential long-term impact of climate-related risks remains uncertain, and regulatory measures to address climate change may materially restrict how the company conducts business or adversely affect its financial results.
• The company may need to make significant additional cash contributions to its retirement benefit plans if investment returns on pension assets are lower than expected or interest rates decline, and/or due to changes to regulatory, accounting, and actuarial requirements.
• Debt obligations could materially adversely affect the company's business and its ability to meet obligations.
• Covenants in debt agreements may impair the ability to operate the business.
• Challenges in the commercial and credit environments may materially adversely affect future access to capital.
• The company may require additional financing in the future to meet capital needs or to make acquisitions, and such financing may not be available on favorable terms, if at all, and may be dilutive to existing stockholders.
• Stockholders' ownership in RYAM may be diluted.
• Certain provisions in the company's amended and restated certificate of incorporation and bylaws, as well as Delaware law, could prevent or delay an acquisition of the company, which could decrease the price of its common stock.

Future Outlook

The company expects to meaningfully grow EBITDA over the two years following 2025, supported by efforts to increase Cellulose Specialties sales volume and margins, accelerate high-return investments in Biomaterials, and implement cost reduction initiatives. The long-term strategy targets over $300 million in run-rate EBITDA by the end of 2027. The company anticipates a rebuild of momentum in the second half of 2025 as near-term pressures are largely considered to have peaked. It aims to restore Paperboard and High-Yield Pulp businesses to historical profitability and position them for divestiture in 2026. Final investment decisions on several Biomaterials projects are expected in 2025.

Management Comments

• "Our second quarter results were impacted by a series of extraordinary and largely non-recurring challenges, including tariff volatility, operational disruptions and significant non-cash charges."
• "These factors, while meaningful in the short term, are now largely behind us."
• "As a result, we revised our 2025 Adjusted EBITDA guidance to $150 to $160 million. Importantly, these headwinds peaked in the second quarter and were already seeing tangible signs of stabilization and recovery entering the second half of the year."
• "Looking ahead, we expect that our long-term plan remains on track to nearly double our EBITDA over the next two years relative to our revised 2025 outlook. This confidence is grounded in the cessation of extraordinary headwinds encountered in 2025 and a clear set of growth drivers."
• "The temporary setbacks we’ve faced this year do not alter the fundamentals of our business or the trajectory we are on—they simply reinforce the importance and impact of the strategy we are executing."

Industry Context

The company's performance reflects broader industry challenges, including global trade disruptions, tariff-driven market volatility, and oversupply in certain segments like High-Yield Pulp in China. Increased competitive activity from new U.S. capacity and EU imports is impacting the Paperboard market. Despite these headwinds, the company is focusing on high-value Cellulose Specialties and Biomaterials, aligning with a trend towards sustainable and advanced materials in the chemical and forestry sectors. The pursuit of bioethanol and Sustainable Aviation Fuel (SAF) projects indicates a strategic pivot towards green energy and renewable products, a growing area of investment and demand.

Comparison to Industry Standards

• The filing mentions 'increased competitive activity due to increased EU imports and the start-up of new U.S. capacity' in the Paperboard segment, indicating a challenging market with new entrants and supply.
• For High-Yield Pulp, the filing notes 'continued oversupply in the Chinese market' and 'lower demand, including in China where demand for all grades of market pulp were down', suggesting a difficult global market for this commodity.
• The company's Biomaterials strategy, including the operational bioethanol facility in France and the re-started lignosulfonate powder plant, along with planned investments in crude tall oil and prebiotics facilities, aligns with a broader industry shift towards bio-based products and renewable energy. The pursuit of eSAF and pilot-scale SAF plants with partners like Verso Energy and GranBio positions the company within the emerging sustainable aviation fuel market, though specific comparable project results are not detailed.

Legal Proceedings

• The company is pursuing all available legal remedies regarding the City of Fernandina Beach's denial of the site plan application for its proposed bioethanol facility.

Stakeholder Impact

• **Shareholders:** Significant net loss and reduced guidance are likely to negatively impact share price and shareholder value. Potential future dilution if additional financing is required.
• **Employees:** Operational challenges, labor strike at Tartas, and production idling in Paperboard and High-Yield Pulp segments could impact employment stability and morale.
• **Customers:** Tariff uncertainty and operational disruptions led to a pause in customer orders and lower sales volumes in Cellulose Specialties. Shifting customer dynamics and increased competitive activity are impacting Paperboard customers.
• **Creditors:** Increased total debt and net secured debt, along with a higher leverage ratio, could be a concern, though the company states it has a 'solid balance sheet'.
• **Suppliers:** Lower production volumes due to operational challenges and idling of plants may reduce demand for raw materials from suppliers.

Next Steps

• Rebuild momentum in the second half of 2025.
• Increase Cellulose Specialties sales volume and expand margins by increasing prices and investing in high-return cost reduction projects.
• Accelerate high-return investments in Biomaterials.
• Restore Paperboard and High-Yield Pulp businesses to historical levels of profitability and position them for divestiture in 2026.
• Continue to pursue legal remedies regarding the denied site plan application for the bioethanol facility in Fernandina Beach, Florida.
• Advance engineering plans and explore potential commercial agreements for the Fernandina Beach bioethanol project.
• Evaluate investments in crude tall oil facilities in Jesup, Georgia and Tartas, and a prebiotics facility at the Jesup plant, working on permitting, engineering, and commercial agreements.
• Continue development of the AGE (Altamaha Green Energy, LLC) project for green electricity generation in Georgia.
• Make final investment decisions on several Biomaterials projects in 2025.
• Adjust production mix in Cellulose Commodities to mitigate the impact of direct tariffs and related second-order effects.
• Idling Paperboard production for two weeks during Q3 to align inventory levels with demand and preserve cash flow.
• Idling High-Yield Pulp production for three weeks during Q3 to proactively manage inventory levels and preserve cash flow.
• Host a conference call and live webcast on August 6, 2025, to discuss results.

Key Dates

Recommendation

The company reported a substantial net loss driven by a significant non-cash write-off and operational challenges, leading to a material downward revision of its full-year Adjusted EBITDA and Adjusted Free Cash Flow guidance. Key strategic initiatives, such as the divestiture of Paperboard and High-Yield Pulp businesses, are on hold, and a critical Biomaterials project faces legal hurdles. While management expresses long-term optimism, the immediate financial performance is severely deteriorated, and the near-term outlook is highly uncertain with continued market headwinds and production curtailments. This combination of poor results, reduced guidance, and strategic delays signals significant downside risk for investors.

Keywords

Cellulose Specialties, Biomaterials, High-Yield Pulp, Paperboard, Specialty Chemicals, Forest Products, Pulp and Paper, Tariffs, EBITDA, Cash Flow, SEC Filing, Q2 Earnings, RYAM